<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39344133</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1474-9726</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Sep</Month><Day>29</Day></PubDate></JournalIssue><Title>Aging cell</Title><ISOAbbreviation>Aging Cell</ISOAbbreviation></Journal><ArticleTitle>Emerging signs of Alzheimer-like tau hyperphosphorylation and neuroinflammation in the brain post recovery from COVID-19.</ArticleTitle><Pagination><StartPage>e14352</StartPage><MedlinePgn>e14352</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/acel.14352</ELocationID><Abstract><AbstractText>Coronavirus disease 2019 (COVID-19) has been suggested to increase the risk of memory decline and Alzheimer's disease (AD), the main cause of dementia in the elderly. However, direct evidence about whether COVID-19 induces AD-like neuropathological changes in the brain, especially post recovery from acute infection, is still lacking. Here, using postmortem human brain samples, we found abnormal accumulation of hyperphosphorylated tau protein in the hippocampus and medial entorhinal cortex within 4-13 months post clinically recovery from acute COVID-19, together with prolonged activation of glia cells and increases in inflammatory factors, even though no SARS-COV-2 invasion was detected in these regions. By contrast, COVID-19 did not change beta-amyloid deposition and hippocampal neuron number, and had limited effects on AD-related pathological phenotypes in olfactory circuits including olfactory bulb, anterior olfactory nucleus, olfactory tubercle, piriform cortex and lateral entorhinal cortex. These results provide neuropathological evidences linking COVID-19 with prognostic increase of risk for AD.</AbstractText><CopyrightInformation>© 2024 The Author(s). Aging Cell published by Anatomical Society and John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Qi</LastName><ForeName>Xuetao</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0003-1449-7268</Identifier><AffiliationInfo><Affiliation>Neuroscience Research Institute and Department of Neurobiology, School of Basic Medical Sciences, Peking University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory for Neuroscience, Ministry of Education/National Health Commission, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Shulu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neuroscience Research Institute and Department of Neurobiology, School of Basic Medical Sciences, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Jiuyang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Key Laboratory of Human Brain Bank for Functions and Diseases of Department of Education of Guizhou Province, Guizhou Medical University, Guiyang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Endemic and Ethnic Diseases, Ministry of Education, Guizhou Medical University, Guiyang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Forensic Medicine, Guizhou Medical University, Guiyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Weiqi</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Neuroscience Research Institute and Department of Neurobiology, School of Basic Medical Sciences, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Yajiao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Neuroscience Research Institute and Department of Neurobiology, School of Basic Medical Sciences, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xing</LastName><ForeName>Yuanwei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Neuroscience Research Institute and Department of Neurobiology, School of Basic Medical Sciences, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zilong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Neuroscience Research Institute and Department of Neurobiology, School of Basic Medical Sciences, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Yun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Neuroscience Research Institute and Department of Neurobiology, School of Basic Medical Sciences, Peking University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory for Neuroscience, Ministry of Education/National Health Commission, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Su</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neuroscience Research Institute and Department of Neurobiology, School of Basic Medical Sciences, Peking University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory for Neuroscience, Ministry of Education/National Health Commission, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Baofei</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Key Laboratory of Human Brain Bank for Functions and Diseases of Department of Education of Guizhou Province, Guizhou Medical University, Guiyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qi</LastName><ForeName>Xiaolan</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-9108-6772</Identifier><AffiliationInfo><Affiliation>Key Laboratory of Endemic and Ethnic Diseases, Ministry of Education, Guizhou Medical University, Guiyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Bing</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>School of Forensic Medicine, Guizhou Medical University, Guiyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Fengyu</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Neuroscience Research Institute and Department of Neurobiology, School of Basic Medical Sciences, Peking University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory for Neuroscience, Ministry of Education/National Health Commission, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yi</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neuroscience Research Institute and Department of Neurobiology, School of Basic Medical Sciences, Peking University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory for Neuroscience, Ministry of Education/National Health Commission, Peking University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Beijing Life Science Academy, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wan</LastName><ForeName>You</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Neuroscience Research Institute and Department of Neurobiology, School of Basic Medical Sciences, Peking University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory for Neuroscience, Ministry of Education/National Health Commission, Peking University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Life Science Academy, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Jie</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-0637-9918</Identifier><AffiliationInfo><Affiliation>Neuroscience Research Institute and Department of Neurobiology, School of Basic Medical Sciences, Peking University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory for Neuroscience, Ministry of Education/National Health Commission, Peking University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Life Science Academy, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>BMU2022YJ003</GrantID><Agency>Peking University Talent Startup Fund</Agency><Country /></Grant><Grant><Agency>Fundamental Research Funds for the Central Universities</Agency><Country /></Grant><Grant><GrantID>2023000CA0060</GrantID><Agency>Scientific Project of Beijing Life Science Academy</Agency><Country /></Grant><Grant><GrantID>2023000CB0010</GrantID><Agency>Scientific Project of Beijing Life Science Academy</Agency><Country /></Grant><Grant><GrantID>2024300CC0020</GrantID><Agency>Scientific Project of Beijing Life Science Academy</Agency><Country /></Grant><Grant><GrantID>Qiankehe Platform Talents-CXTD[2023]003</GrantID><Agency>Guizhou Provincial Science and Technology Program Project Grant</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Aging Cell</MedlineTA><NlmUniqueID>101130839</NlmUniqueID><ISSNLinking>1474-9718</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer's disease</Keyword><Keyword MajorTopicYN="N">COVID‐19</Keyword><Keyword MajorTopicYN="N">glia cell</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">tau</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>1</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39344133</ArticleId><ArticleId IdType="doi">10.1111/acel.14352</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Amruta, N., Ismael, S., Leist, S. R., Gressett, T. E., Srivastava, A., Dinnon, K. R., Engler‐Chiurazzi, E. B., Maness, N. J., Qin, X., Kolls, J. K., Baric, R. S., &amp; Bix, G. (2022). Mouse adapted SARS‐CoV‐2 (MA10) viral infection induces neuroinflammation in standard laboratory mice. Viruses, 15, 15.</Citation></Reference><Reference><Citation>Bonhenry, D., Charnley, M., Goncalves, J., Hammarstrom, P., Heneka, M. T., Itzhaki, R., Lambert, J. C., Mannan, M., Baig, A. M., Middeldorp, J., Nyström, S., Reynolds, N. P., Stefanatou, M., &amp; Berryman, J. T. (2024). SARS‐CoV‐2 infection as a cause of neurodegeneration. Lancet Neurology, 23, 562–563.</Citation></Reference><Reference><Citation>Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., &amp; Del, T. K. (2006). Staging of Alzheimer disease‐associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathologica, 112, 389–404.</Citation></Reference><Reference><Citation>Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., Zhang, X., Zhang, M., Wu, S., Song, J., Chen, T., Han, M., Li, S., Luo, X., Zhao, J., &amp; Ning, Q. (2020). Clinical and immunological features of severe and moderate coronavirus disease 2019. The Journal of Clinical Investigation, 130, 2620–2629.</Citation></Reference><Reference><Citation>Chen, Y., &amp; Yu, Y. (2023). Tau and neuroinflammation in Alzheimer's disease: Interplay mechanisms and clinical translation. Journal of Neuroinflammation, 20, 165.</Citation></Reference><Reference><Citation>Di Primio, C., Quaranta, P., Mignanelli, M., Siano, G., Bimbati, M., Scarlatti, A., Piazza, C. R., Spezia, P. G., Perrera, P., Basolo, F., Poma, A. M., Costa, M., Pistello, M., &amp; Cattaneo, A. (2023). Severe acute respiratory syndrome coronavirus 2 infection leads to tau pathological signature in neurons. PNAS Nexus, 2, pgad282.</Citation></Reference><Reference><Citation>Doty, R. L. (2022). Olfactory dysfunction in COVID‐19: Pathology and long‐term implications for brain health. Trends in Molecular Medicine, 28, 781–794.</Citation></Reference><Reference><Citation>Douaud, G., Lee, S., Alfaro‐Almagro, F., Arthofer, C., Wang, C., McCarthy, P., Lange, F., Andersson, J., Griffanti, L., Duff, E., Jbabdi, S., Taschler, B., Keating, P., Winkler, A. M., Collins, R., Matthews, P. M., Allen, N., Miller, K. L., Nichols, T. E., &amp; Smith, S. M. (2022). SARS‐CoV‐2 is associated with changes in brain structure in UK biobank. Nature, 604, 697–707.</Citation></Reference><Reference><Citation>Emmi, A., Rizzo, S., Barzon, L., Sandre, M., Carturan, E., Sinigaglia, A., Riccetti, S., Della, B. M., Boscolo‐Berto, R., Cocco, P., Macchi, V., Antonini, A., De Gaspari, M., Basso, C., De Caro, R., &amp; Porzionato, A. (2023). Detection of SARS‐CoV‐2 viral proteins and genomic sequences in human brainstem nuclei. NPJ Parkinsons Dis, 9, 25.</Citation></Reference><Reference><Citation>Gagliardi, S., Poloni, E. T., Pandini, C., Garofalo, M., Dragoni, F., Medici, V., Davin, A., Visona, S. D., Moretti, M., Sproviero, D., Pansarasa, O., Guaita, A., Ceroni, M., Tronconi, L., &amp; Cereda, C. (2021). Detection of SARS‐CoV‐2 genome and whole transcriptome sequencing in frontal cortex of COVID‐19 patients. Brain, Behavior, and Immunity, 97, 13–21.</Citation></Reference><Reference><Citation>Hampshire, A., Azor, A., Atchison, C., Trender, W., Hellyer, P. J., Giunchiglia, V., Husain, M., Cooke, G. S., Cooper, E., Lound, A., Donnelly, C. A., Chadeau‐Hyam, M., Ward, H., &amp; Elliott, P. (2024). Cognition and memory after Covid‐19 in a large community sample. The New England Journal of Medicine, 390, 806–818.</Citation></Reference><Reference><Citation>Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., Cheng, Z., Yu, T., Xia, J., Wei, Y., Wu, W., Xie, X., Yin, W., Li, H., Liu, M., … Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan China. Lancet, 395, 497–506.</Citation></Reference><Reference><Citation>Huang, S., Zhou, Z., Yang, D., Zhao, W., Zeng, M., Xie, X., Du, Y., Jiang, Y., Zhou, X., Yang, W., Guo, H., Sun, H., Liu, P., Liu, J., Luo, H., &amp; Liu, J. (2022). Persistent white matter changes in recovered COVID‐19 patients at the 1‐year follow‐up. Brain, 145, 1830–1838.</Citation></Reference><Reference><Citation>Ising, C., Venegas, C., Zhang, S., Scheiblich, H., Schmidt, S. V., Vieira‐Saecker, A., Schwartz, S., Albasset, S., McManus, R. M., Tejera, D., Griep, A., Santarelli, F., Brosseron, F., Opitz, S., Stunden, J., Merten, M., Kayed, R., Golenbock, D. T., Blum, D., … Heneka, M. T. (2019). NLRP3 inflammasome activation drives tau pathology. Nature, 575, 669–673.</Citation></Reference><Reference><Citation>Jagust, W. (2018). Imaging the evolution and pathophysiology of Alzheimer disease. Nature Reviews. Neuroscience, 19, 687–700.</Citation></Reference><Reference><Citation>Leng, F., &amp; Edison, P. (2021). Neuroinflammation and microglial activation in Alzheimer disease: Where do we go from here? Nature Reviews. Neurology, 17, 157–172.</Citation></Reference><Reference><Citation>Long, J. M., &amp; Holtzman, D. M. (2019). Alzheimer disease: An update on pathobiology and treatment strategies. Cell, 179, 312–339.</Citation></Reference><Reference><Citation>Matschke, J., Lutgehetmann, M., Hagel, C., Sperhake, J. P., Schroder, A. S., Edler, C., Mushumba, H., Fitzek, A., Allweiss, L., Dandri, M., Dottermusch, M., Heinemann, A., Pfefferle, S., Schwabenland, M., Sumner Magruder, D., Bonn, S., Prinz, M., Gerloff, C., Püschel, K., … Glatzel, M. (2020). Neuropathology of patients with COVID‐19 in Germany: A post‐mortem case series. Lancet Neurology, 19, 919–929.</Citation></Reference><Reference><Citation>Murphy, C. (2019). Olfactory and other sensory impairments in Alzheimer disease. Nature Reviews. Neurology, 15, 11–24.</Citation></Reference><Reference><Citation>Olivera, E., Saez, A., Carniglia, L., Caruso, C., Lasaga, M., &amp; Durand, D. (2023). Alzheimer's disease risk after COVID‐19: A view from the perspective of the infectious hypothesis of neurodegeneration. Neural Regeneration Research, 18, 1404–1410.</Citation></Reference><Reference><Citation>Ossenkoppele, R., van der Kant, R., &amp; Hansson, O. (2022). Tau biomarkers in Alzheimer's disease: Towards implementation in clinical practice and trials. Lancet Neurology, 21, 726–734.</Citation></Reference><Reference><Citation>Ramani, A., Muller, L., Ostermann, P. N., Gabriel, E., Abida‐Islam, P., Muller‐Schiffmann, A., Mariappan, A., Goureau, O., Gruell, H., Walker, A., Andrée, M., Hauka, S., Houwaart, T., Dilthey, A., Wohlgemuth, K., Omran, H., Klein, F., Wieczorek, D., Adams, O., … Gopalakrishnan, J. (2020). SARS‐CoV‐2 targets neurons of 3D human brain organoids. The EMBO Journal, 39, e106230.</Citation></Reference><Reference><Citation>Schwabenland, M., Salie, H., Tanevski, J., Killmer, S., Lago, M. S., Schlaak, A. E., Mayer, L., Matschke, J., Puschel, K., Fitzek, A., Ondruschka, B., Mei, H. E., Boettler, T., Neumann‐Haefelin, C., Hofmann, M., Breithaupt, A., Genc, N., Stadelmann, C., Saez‐Rodriguez, J., … Bengsch, B. (2021). Deep spatial profiling of human COVID‐19 brains reveals neuroinflammation with distinct microanatomical microglia‐T‐cell interactions. Immunity, 54, 1594–1610.</Citation></Reference><Reference><Citation>Stein, S. R., Ramelli, S. C., Grazioli, A., Chung, J. Y., Singh, M., Yinda, C. K., Winkler, C. W., Sun, J., Dickey, J. M., Ylaya, K., Ko, S. H., Platt, A. P., Burbelo, P. D., Quezado, M., Pittaluga, S., Purcell, M., Munster, V. J., Belinky, F., Ramos‐Benitez, M. J., … Chertow, D. S. (2022). SARS‐CoV‐2 infection and persistence in the human body and brain at autopsy. Nature, 612, 758–763.</Citation></Reference><Reference><Citation>Sun, B., Tang, N., Peluso, M. J., Iyer, N. S., Torres, L., Donatelli, J. L., Munter, S. E., Nixon, C. C., Rutishauser, R. L., Rodriguez‐Barraquer, I., Greenhouse, B., Kelly, J. D., Martin, J. N., Deeks, S. G., Henrich, T. J., &amp; Pulliam, L. (2021). Characterization and biomarker analyses of post‐COVID‐19 complications and neurological manifestations. Cells, 10, 10.</Citation></Reference><Reference><Citation>Thaweethai, T., Jolley, S. E., Karlson, E. W., Levitan, E. B., Levy, B., McComsey, G. A., McCorkell, L., Nadkarni, G. N., Parthasarathy, S., Singh, U., Walker, T. A., Selvaggi, C. A., Shinnick, D. J., Schulte, C. C. M., Atchley‐Challenner, R., Alba, G. A., Alicic, R., Altman, N., Anglin, K., … RECOVER Consortium (2023). (2023). Development of a definition of Postacute sequelae of SARS‐CoV‐2 infection. Journal of the American Medical Association, 329, 1934–1946.</Citation></Reference><Reference><Citation>Tsukahara, T., Brann, D. H., &amp; Datta, S. R. (2023). Mechanisms of SARS‐CoV‐2‐associated anosmia. Physiological Reviews, 103, 2759–2766.</Citation></Reference><Reference><Citation>van der Kant, R., Goldstein, L., &amp; Ossenkoppele, R. (2020). Amyloid‐beta‐independent regulators of tau pathology in Alzheimer disease. Nature Reviews. Neuroscience, 21, 21–35.</Citation></Reference><Reference><Citation>Woo, M. S., Malsy, J., Pottgen, J., Seddiq, Z. S., Ufer, F., Hadjilaou, A., Schmiedel, S., Addo, M. M., Gerloff, C., Heesen, C., Schulze Zur Wiesch, J., &amp; Friese, M. A. (2020). Frequent neurocognitive deficits after recovery from mild COVID‐19. Brain Commun, 2, fcaa205.</Citation></Reference><Reference><Citation>Woodburn, S. C., Bollinger, J. L., &amp; Wohleb, E. S. (2021). The semantics of microglia activation: Neuroinflammation, homeostasis, and stress. Journal of Neuroinflammation, 18, 258.</Citation></Reference><Reference><Citation>Zhang, P. P., He, Z. C., Yao, X. H., Tang, R., Ma, J., Luo, T., Zhu, C., Li, T. R., Liu, X., Zhang, D., Zhang, S., Ping, Y. F., Leng, L., &amp; Bian, X. W. (2023). COVID‐19‐associated monocytic encephalitis (CAME): Histological and proteomic evidence from autopsy. Signal Transduction and Targeted Therapy, 8, 24.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>